Fagiolini A, Matone A, Gaz C, et al. Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia. Farmeconomia. Health Economics and Therapeutic Pathways. 2011;12(1):29-40. https://doi.org/10.7175/fe.v12i1.96